• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Postoperative and nonoperative atrial fibrillation have a similar risk of associated thromboembolism

byDavid XiangandKiera Liblik
August 11, 2022
in Cardiology, Neurology
Reading Time: 2 mins read
Radiofrequency catheter ablation effective as first-line therapy for atrial fibrillation [RAAFT-2 trial]
Share on FacebookShare on Twitter

1. Postoperative atrial fibrillation had a similar risk for associated stroke or transient ischemic attack (TIA) as compared to nonoperative atrial fibrillation.

2. Those with postoperative atrial fibrillation had a lower risk for subsequent atrial fibrillation.

Evidence Rating Level: 1 (Excellent)

Study Rundown: New-onset atrial fibrillation can occur sporadically or be triggered by factors such as the perioperative state. In these instances, perioperative stress and systemic inflammation may contribute to the development of atrial fibrillation. However, there is a gap in knowledge as to understanding how postoperative atrial fibrillation after noncardiac surgery compares with atrial fibrillation occurring outside of the operative setting with respect to subsequent risk for nonfatal and fatal outcomes. Overall, this study found that in patients undergoing noncardiac surgery, atrial fibrillation occurring postoperatively is associated with similar risks for stroke and TIA and cardiovascular-related as well as all-cause death compared with other atrial fibrillation documented outside of the operative setting. This study was limited by the study population being not very racially diverse, as well as no information to categorize atrial fibrillation as paroxysmal or persistent, and residual confounding in the associations between demographic characteristics and postoperative and nonoperative atrial fibrillation groups. Nevertheless, these study’s findings are significant, as they demonstrate that postoperative atrial fibrillation that develops after non-cardiac surgery has similar risks as nonoperative atrial fibrillation in terms of risk of developing stroke, TIA, or cardiovascular-related death.

Click to read the study in AIM

Relevant Reading: Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

2 Minute Medicine Rewind September 7, 2026

In-Depth [cohort study]: This cohort study utilized the Rochester Epidemiology Project medical records system. Patients who are aged 18 years or older, from Olmsted County, Minnesota, with incident atrial fibrillation diagnosed between January 2000 and December 2013 were eligible for the study. Patients with atrial fibrillation occurring within 30 days of heart or large thoracic vessel surgery were excluded from the study. The primary outcome measure was the composite of ischemic stroke or TIA, with secondary outcomes such as subsequent atrial fibrillation, all-cause death, and cardiovascular-related death also studied. Outcomes in the primary analysis were assessed via Kaplan-Meier cumulative incidence plots as well as 2-sample t-tests. Based on the primary analysis, 4,231 patients had incident atrial fibrillation, with 550 of them having postoperative atrial fibrillation as their first-ever documented atrial fibrillation presentation. Over a mean follow-up of 6.3 years, 486 patients had an ischemic stroke or TIA, and 2,462 had subsequent atrial fibrillation, with a total of 2,565 deaths. Between postoperative atrial fibrillation and nonoperative atrial fibrillation groups, the risk for stroke or TIA was similar (absolute risk difference at 5 years, 0.1%; 95% Confidence Interval, -2.9% to 3.1%). No significant difference was observed for cardiovascular death or all-cause death in patients with postoperative atrial fibrillation or nonoperative atrial fibrillation. Overall, this study demonstrates that postoperative atrial fibrillation after noncardiac surgery is associated with similar risks for stroke, TIA, and cardiovascular-related deaths compared to nonoperative atrial fibrillation patients.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atrial fibrillationcardiologyinternal medicineneurologynon-operative atrial fibrillationpost-operative atrial fibrillationstrokeTransient Ischemic Attack
Previous Post

MRI offers an alternative to endoscopic assessment of disease activity and severity in ileocolonic Crohn’s disease [Classics Series]

Next Post

Baricitinib reduces mortality risk in patients hospitalized with COVID-19

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Baricitinib reduces mortality risk in patients hospitalized with COVID-19

Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

Prior syncope presentation not associated with increased risk of motor vehicle collision

Prasinezumab therapy does not affect Parkinson’s Disease progression

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.